Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.50
Bid: 51.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.882%)
Open: 52.50
High: 52.50
Low: 52.50
Prev. Close: 52.50
FEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

12 Oct 2021 11:15

RNS Number : 8083O
Frenkel Topping Group PLC
12 October 2021
 

Frenkel Topping Group plc

("Frenkel Topping", the "Company" or the "Group")

Director/PDMR Shareholding

Frenkel Topping Group (AIM: FEN), a specialist professional and financial services firm focused on asset protection for clients, announces that, further to the recent Holding in Company announcement released on 11 October 2021, confirming that Harwood Capital LLP as investment manager to North Atlantic Smaller Companies Investment Trust plc ("NASCIT") had purchased 351,741 ordinary shares of 0.5p each in the capital of the Company ("Ordinary Shares"), at a price of 73 pence per Ordinary Share (the "Purchase"), Christopher Mills, Non-executive Director of the Company and a director of NASCIT, is now interested in 27,500,000 Ordinary Shares of the Company, representing approximately 24.3 per cent. of the Company's issued share capital.

For further information:

Frenkel Topping Group plc

www.frenkeltoppinggroup.co.uk

Richard Fraser, Chief Executive Officer

Tel: 0161 886 8000

finnCap Ltd (Nominated Advisor & Broker)

Tel: 020 7220 0500

Carl Holmes/James Thompson/Milesh Hindocha (Corporate Finance)

Richard Chambers (ECM)

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Harwood Capital LLP as investment manager to NASCIT.

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Harwood Capital LLP and NASCIT are PCAs of Christopher Mills, Non-Executive Director of Frenkel Topping plc

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Frenkel Topping Group plc

b)

 

LEI

 

 

213800I5L3K7AT7A4R20

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

Identification code

GB00B01YXQ71

 

b)

 

Nature of the transaction

 

 

Share purchase

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.7325

351,741

d)

 

Aggregated information

- Aggregated volume

351,741

- Price

£257,650.28

e)

 

Date of the transaction

 

 

8 October 2021

f)

 

Place of the transaction

 

 

London Stock Exchange

 

The Company also confirms that it received the below notification today covering a previous dealing by Harwood Capital LLP as investment manager to NASCIT completed on the 1 October 2021.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Harwood Capital LLP as investment manager to NASCIT.

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Harwood Capital LLP and NASCIT are PCAs of Christopher Mills, Non-Executive Director of Frenkel Topping plc

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Frenkel Topping Group plc

b)

 

LEI

 

 

213800I5L3K7AT7A4R20

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

Identification code

GB00B01YXQ71

 

b)

 

Nature of the transaction

 

 

Share purchase

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.712

648,259

d)

 

Aggregated information

- Aggregated volume

648,259

- Price

£461,560.40

e)

 

Date of the transaction

 

 

1 October 2021

f)

 

Place of the transaction

 

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLLFFFBLBFBL
Date   Source Headline
1st May 202410:25 amRNSHolding(s) in Company
23rd Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
22nd Apr 20247:01 amRNSAcquisition
22nd Apr 20247:00 amRNSFinal Results
12th Mar 20247:00 amRNSNotice of Results
20th Feb 20247:00 amRNSDirectorate Change
24th Jan 20247:00 amRNSTrading Update & New Debt Facility
22nd Dec 20238:00 amRNSHolding(s) in Company
13th Nov 20237:00 amRNSPartnership Programme Grows with New Joint Venture
8th Nov 20234:30 pmRNSDirector/PDMR Shareholding
3rd Nov 20238:30 amRNSHolding(s) in Company
3rd Oct 20237:00 amRNSThe Shares and AJ Bell Media investor event
3rd Oct 20237:00 amRNSAppointment of Strategy & Implementation Director
29th Sep 20237:00 amRNSInterim Results
31st Aug 202310:08 amRNSDirector/PDMR Shareholding
29th Aug 20237:00 amRNSDirector Share Purchase
22nd Aug 20237:00 amRNSTrading Update
31st Jul 20237:00 amRNSFEN Announces Joint Venture with Lime Solicitors
21st Jul 20233:20 pmRNSIssue of consideration shares
6th Jul 20237:00 amRNSFEN announces New Major Trauma Centre
20th Jun 20237:00 amRNSDirector/PDMR Shareholding
14th Jun 202312:20 pmRNSResult of AGM
5th Jun 20237:00 amRNSFEN announces New Major Trauma Centre
15th May 20234:15 pmRNSAnnual Report Posting, Notice of AGM & Dividend
24th Apr 20237:00 amRNSFinal Results
22nd Mar 20234:00 pmRNSHolding(s) in Company
15th Mar 202311:47 amRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSInvestor Presentation
13th Feb 20237:00 amRNSFrenkel Topping Partnership Programme Grows
7th Feb 20237:00 amRNSTrading Update and Notice of Results
10th Nov 20222:50 pmRNSInterim Dividend Timetable
3rd Nov 20227:00 amRNSFEN to present at AJ Bell investor webinar
24th Oct 20222:30 pmRNSDirector/PDMR Shareholding and Holdings in Company
24th Oct 202212:15 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
13th Sep 20227:00 amRNSCompletion of Two Acquisitions
31st Aug 20222:15 pmRNSNotice of Results
3rd Aug 202210:17 amRNSHolding(s) in Company
3rd Aug 202210:15 amRNSHolding(s) in Company
29th Jul 202212:15 pmRNSResult of General Meeting
25th Jul 20227:00 amRNSFEN Announces Joint Venture with CFG Law
25th Jul 20227:00 amRNSFEN Announces Joint Venture with CFG Law
12th Jul 202210:50 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSResults of Placing
5th Jul 20222:45 pmRNSProposed Placing to raise approximately £10m
22nd Jun 202211:40 amRNSResult of AGM
16th May 20228:25 amRNSAnnual Report Posting, Notice of AGM & Dividend
4th May 20221:00 pmRNSDirector/PDMR Shareholding
25th Apr 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.